Cleared Traditional

K832788 - INFUSE-A-PORT

K832788 is an FDA 510(k) clearance for INFUSE-A-PORT, manufactured by Infusaid Corp.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 27-day FDA review.

K832788 · Infusaid Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1983
Decision
27d
Days
Class 2
Risk

K832788 is an FDA 510(k) clearance for the INFUSE-A-PORT. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Infusaid Corp. (Mchenry, US). The FDA issued a Cleared decision on September 15, 1983 after a review of 27 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Infusaid Corp. devices

FDA 510(k) Submission Details - K832788

510(k) Number K832788 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 19, 1983
Decision Date September 15, 1983
Days to Decision 27 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
102d faster than avg
Panel avg: 129d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 244
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K832788.
VASCULAR-ACCESS PORT - ENLARGEMENT
K841149 · Norfolk Medical Products, Inc. · Apr 1984
VASCULAR-ACCESS PORT CHANGE CATHETER
K841150 · Norfolk Medical Products, Inc. · Apr 1984
PORT-A-CATH
K832917 · Pharmacia, Inc. · Dec 1983
PORT-A-CATH IMPLANTABLE CATH. SYS
K830730 · Pharmacia, Inc. · Jun 1983
VASCULAR-ACCESS-PORT
K830000 · Norfolk Medical Products, Inc. · Mar 1983